Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 26, 2001

View Archived Issues

MorphoSys Sells 10% Stake As Part Of Schering Collaboration

Parasites Yield Clues That Could Lead To Therapeutic Approaches

CAT Expands Pipeline Through Alliances With Incyte, Amrad

Gyros Raises $30M To Fund Microlab Production Plant

Mindset Gets $15M Commitment To Help Fund CNS Programs

GroPep Gains Manufacturing Capability Through Purchase

Biota Wants To Improve Pipeline, Business; CEO Stepping Down

Pharmacore Raises $4.5M To Fund Development Programs

Merck Takes Celltech Compound Forward; Separate Drug Sidelined

Other News To Note

Recombinant Factor VIIa Used Successfully In Trauma Setting

Largest UK Cancer Charities Merging Into One Organization

Xantos Raises EUR21M To Fund Functional Genomics, Screening

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...